Czechia – Immunosuppressive agents – Imunosupresiva - inhibitory TNF alfa II.

The subject of the public contract is the supply of medicinal products for parenteral administration from the group of TNF alfa inhibitors (infliximab and adalimumab) for the treatment of patients in approved indications according to the Summary of Product Characteristics (SmPC) valid on the date of submission of the tender.